Andreas H Zisch

Summary

Affiliation: Swiss Federal Institute of Technology
Country: Switzerland

Publications

  1. ncbi Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth
    Andreas H Zisch
    Department of Materials Science and Institute for Biomedical Engineering, Swiss Federal Institute of Technology Zurich and University of Zurich, Switzerland
    FASEB J 17:2260-2. 2003
  2. ncbi Biopolymeric delivery matrices for angiogenic growth factors
    Andreas H Zisch
    Institute for Biomedical Engineering and Department of Materials Science, Swiss Federal Institute of Technology Zurich ETHZ, Moussonstrasse 18, 8044 Zurich, Switzerland
    Cardiovasc Pathol 12:295-310. 2003
  3. ncbi Tissue engineering of angiogenesis with autologous endothelial progenitor cells
    Andreas H Zisch
    Department of Obstetrics, University Hospital Zurich, Frauenklinikstr 10, 8091, Switzerland
    Curr Opin Biotechnol 15:424-9. 2004
  4. ncbi Engineered fibrin matrices for functional display of cell membrane-bound growth factor-like activities: study of angiogenic signaling by ephrin-B2
    Andreas H Zisch
    Department of Materials Science, Institute for Biomedical Engineering, ETH Zurich, University of Zurich, Moussonstr 18, 8044 Zurich, Switzerland
    Biomaterials 25:3245-57. 2004
  5. ncbi Effects of protein and gene transfer of the angiopoietin-1 fibrinogen-like receptor-binding domain on endothelial and vessel organization
    Cornelia C Weber
    Department of Materials Science, and Institute of Biomedical Engineering, Swiss Federal Institute of Technology Zurich and University of Zurich, Zurich 8044, Switzerland
    J Biol Chem 280:22445-53. 2005
  6. ncbi Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth
    Martin Ehrbar
    Institute for Biomedical Engineering, and University of Zurich, Zurich, Switzerland
    Circ Res 94:1124-32. 2004
  7. ncbi Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity
    Martin Ehrbar
    Institute for Biomedical Engineering, ETH and University of Zurich, Zurich, Switzerland
    J Control Release 101:93-109. 2005
  8. ncbi Adult 'endothelial progenitor cells'. Renewing vasculature
    Prisca Zammaretti
    Institute for Biomedical Engineering, ETH and University of Zurich, Moussonstr 18, 8044 Zurich, Switzerland
    Int J Biochem Cell Biol 37:493-503. 2005
  9. ncbi Broad-spectrum protein biosensors for class-specific detection of antibiotics
    Cornelia C Weber
    Institute for Biomedical Engineering, Swiss Federal Institute of Technology, ETH Zurich, CH 8044 Zurich, Switzerland
    Biotechnol Bioeng 89:9-17. 2005
  10. doi pH-controlled recovery of placenta-derived mesenchymal stem cell sheets
    Orane Guillaume-Gentil
    Laboratory of Biosensors and Bioelectronics, Institute for Biomedical Engineering, ETH Zurich, Switzerland
    Biomaterials 32:4376-84. 2011

Collaborators

Detail Information

Publications17

  1. ncbi Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth
    Andreas H Zisch
    Department of Materials Science and Institute for Biomedical Engineering, Swiss Federal Institute of Technology Zurich and University of Zurich, Switzerland
    FASEB J 17:2260-2. 2003
    ....
  2. ncbi Biopolymeric delivery matrices for angiogenic growth factors
    Andreas H Zisch
    Institute for Biomedical Engineering and Department of Materials Science, Swiss Federal Institute of Technology Zurich ETHZ, Moussonstrasse 18, 8044 Zurich, Switzerland
    Cardiovasc Pathol 12:295-310. 2003
    ..Another promising venue to improve angiogenic performance is presented by biomaterials that allow sequential delivery of growth factors with complementary roles in blood vessel initiation and stabilization...
  3. ncbi Tissue engineering of angiogenesis with autologous endothelial progenitor cells
    Andreas H Zisch
    Department of Obstetrics, University Hospital Zurich, Frauenklinikstr 10, 8091, Switzerland
    Curr Opin Biotechnol 15:424-9. 2004
    ..Autologous endothelial progenitor cells can also substitute for native vessel-derived endothelial cells in tissue-engineered vascular autografts...
  4. ncbi Engineered fibrin matrices for functional display of cell membrane-bound growth factor-like activities: study of angiogenic signaling by ephrin-B2
    Andreas H Zisch
    Department of Materials Science, Institute for Biomedical Engineering, ETH Zurich, University of Zurich, Moussonstr 18, 8044 Zurich, Switzerland
    Biomaterials 25:3245-57. 2004
    ....
  5. ncbi Effects of protein and gene transfer of the angiopoietin-1 fibrinogen-like receptor-binding domain on endothelial and vessel organization
    Cornelia C Weber
    Department of Materials Science, and Institute of Biomedical Engineering, Swiss Federal Institute of Technology Zurich and University of Zurich, Zurich 8044, Switzerland
    J Biol Chem 280:22445-53. 2005
    ..Furthermore, we show that the isolated receptor-binding domain of Ang1 is capable of mediating some effects of full-length Ang1 independently of Tie2 phosphorylation, possibly through integrin ligation...
  6. ncbi Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth
    Martin Ehrbar
    Institute for Biomedical Engineering, and University of Zurich, Zurich, Switzerland
    Circ Res 94:1124-32. 2004
    ..In conclusion, cell-demanded release of engineered VEGF121 from fibrin implants may present a therapeutically safe and practical modality to induce local angiogenesis...
  7. ncbi Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity
    Martin Ehrbar
    Institute for Biomedical Engineering, ETH and University of Zurich, Zurich, Switzerland
    J Control Release 101:93-109. 2005
    ....
  8. ncbi Adult 'endothelial progenitor cells'. Renewing vasculature
    Prisca Zammaretti
    Institute for Biomedical Engineering, ETH and University of Zurich, Moussonstr 18, 8044 Zurich, Switzerland
    Int J Biochem Cell Biol 37:493-503. 2005
    ..Moreover, endothelial progenitors represent a potential target of strategies to block tumor growth...
  9. ncbi Broad-spectrum protein biosensors for class-specific detection of antibiotics
    Cornelia C Weber
    Institute for Biomedical Engineering, Swiss Federal Institute of Technology, ETH Zurich, CH 8044 Zurich, Switzerland
    Biotechnol Bioeng 89:9-17. 2005
    ..Binding of biosensor protein to the cognate DNA chemically linked to a solid surface is converted into an immuno-based colorimetric readout correlating with specific antibiotics concentrations...
  10. doi pH-controlled recovery of placenta-derived mesenchymal stem cell sheets
    Orane Guillaume-Gentil
    Laboratory of Biosensors and Bioelectronics, Institute for Biomedical Engineering, ETH Zurich, Switzerland
    Biomaterials 32:4376-84. 2011
    ..This novel polyelectrolyte multilayer based platform represents a promising, novel approach for the engineering of human stem cell sheets desired for future clinical applications...
  11. pmc Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism
    Cara Lynn E Helm
    Department of Chemical and Biological Engineering, Northwestern University, Evanston, IL 60208, USA
    Proc Natl Acad Sci U S A 102:15779-84. 2005
    ..This work thus demonstrates a general mechanism of morphogen gradient generation and amplification by small ubiquitous mechanical forces that are known to exist in vivo...
  12. ncbi Enhanced intimal thickening of expanded polytetrafluoroethylene grafts coated with fibrin or fibrin-releasing vascular endothelial growth factor in the pig carotid artery interposition model
    Beat H Walpoth
    Clinic of Cardiovascular Surgery, University of Geneva, Switzerland
    J Thorac Cardiovasc Surg 133:1163-70. 2007
    ..Vascular endothelial growth factor is a potent stimulus for endothelial growth, and its provision in a fibrin matrix coating at the luminal graft surface may hold a key to spontaneous graft endothelialization and improved graft patency...
  13. ncbi The role of actively released fibrin-conjugated VEGF for VEGF receptor 2 gene activation and the enhancement of angiogenesis
    Martin Ehrbar
    Department of Cranio Maxillofacial Surgery, University Hospital Zurich, Switzerland
    Biomaterials 29:1720-9. 2008
    ..In the absence of true physiological demand, even stabilized vessels are ultimately regressed...
  14. doi The dosage dependence of VEGF stimulation on scaffold neovascularisation
    Neil Davies
    Cardiovascular Research Unit, Chris Barnard Division of Cardiothoracic Surgery, University of Cape Town, Department of Health Sciences, 203 Cape Heart Centre, Anzio Road, Observatory, 7925 Cape Town, South Africa
    Biomaterials 29:3531-8. 2008
    ..These results suggest concentration of VEGF plays a critical role in the nature and persistence of vasculature formed in a tissue regenerative scaffold...
  15. pmc Conditional human VEGF-mediated vascularization in chicken embryos using a novel temperature-inducible gene regulation (TIGR) system
    Wilfried Weber
    Institute of Biotechnology, Swiss Federal Institute of Technology Zurich, ETH Hoenggerberg, CH 8093 Zurich, Switzerland
    Nucleic Acids Res 31:e69. 2003
    ..Implantation of microencapsulated DT40 cells engineered for TIGR-controlled expression of the human vascular endothelial growth factor A (hVEGF121) provided low-temperature-induced VEGF-mediated vascularization in chicken embryos...
  16. ncbi MnSOD marks cord blood late outgrowth endothelial cells and accompanies robust resistance to oxidative stress
    Hao Cai
    Department of Obstetrics, University Hospital Zurich, Switzerland
    Biochem Biophys Res Commun 350:364-9. 2006
    ..Such cytoprotective levels of MnSOD cells could give therapeutic cell transplants a survival advantage in necrotic or ischemic conditions...
  17. ncbi Enzymatic formation of modular cell-instructive fibrin analogs for tissue engineering
    Martin Ehrbar
    Oral Biology, Section Bioengineering, Department of Cranio Maxillofacial Surgery, University Hospital Zurich, Zurich, Switzerland
    Biomaterials 28:3856-66. 2007
    ..The synthetic ease and potential to engineer their physicochemical and bioactive characteristics makes these hybrid networks true alternatives for fibrin as provisional drug delivery platforms in tissue engineering...